Comparison of the effectiveness of sertraline and Nortriptyline on anxiety and gastrointestinal symptoms in patients with irritable bowel syndrome
Phase 3
Recruiting
- Conditions
- Irritable bowel syndromeirritable bowel syndrome.
- Registration Number
- IRCT20190618043934N13
- Lead Sponsor
- Birjand University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 192
Inclusion Criteria
Age 18 to 50 years
Patient consent to participate in the study
Exclusion Criteria
Lack of patient cooperation to participate in further study
History of gastrointestinal cancer
History of neurological disorder
Pregnancy and lactation
Bipolar or bipolar patients
Contraindications to the use of two drugs sertraline and nortriptyline
Use of antidepressants and anti-anxiety drugs
Allergy to prescription drugs
Co-occurring with serious physical illnesses such as heart disease, multiple sclerosis
Having a psychotic illness such as schizophrenia and related disorders
Substance abuse and substance abuse
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Anxiety. Timepoint: At the beginning of the study and one month after the start of the intervention in patients. Method of measurement: Beck Anxiety Questionnaire.
- Secondary Outcome Measures
Name Time Method